BioSupply Trends Quarterly logo
Subscribe

Industry News

Research, Science & Manufacturer Updates

Vaccines Articles

Fluzone High-Dose More Effective Than Standard Dose in Older Adults

Results from a large clinical trial of Sanofi Pasteur’s Fluzone High-Dose showed that the influenza vaccine was 24.2 percent more effective against lab-confirmed flu than the traditional vaccine dose in adults 65 and older.
BioSupply Trends Quarterly logo
FFF Enterprises logo
Facebook-f Instagram Linkedin-in Youtube

FFF Enterprises.com | Privacy Statement | Terms of Use | California Consumer Privacy Act (CCPA) Opt-Out Icon

FFF Enterprises.com
Privacy Statement
Terms of Use
California Consumer Privacy Act (CCPA) Opt-Out Icon

©2024 FFF Enterprises, Inc. All Rights Reserved. Property of FFF Enterprises, Inc.

The information provided on this website is not medical advice, nor is it intended to be a substitute for medical advice, diagnosis, and treatment. Always seek the advice of a physician or other qualified health provider with questions concerning a medical condition. Never disregard professional medical advice, or delay seeking it based on information provided on this website.